Back
Intellia Therapeutics Stock Price Chart
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
26
NTLA
Intellia Therapeutics
Last Price:
21.98
Seasonality Move:
34.01%
7 Day Trial
ALL ACCESS PASS
$
7
9,530x the last time this happened
Here's what our expert says you should buy before April 14.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.22 | Sell |
| 20-day SMA: | 23.36 | Sell |
| 50-day SMA: | 26.53 | Sell |
| 200-day SMA: | 30.62 | Sell |
| 8-day EMA: | 21.41 | Sell |
| 20-day EMA: | 23.08 | Sell |
| 50-day EMA: | 25.29 | Sell |
| 200-day EMA: | 30.63 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.71 | Sell |
| Relative Strength Index (14 RSI): | 31 | Sell |
| Chaikin Money Flow: | 738341 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.75 - 26.39) | Sell |
| Bollinger Bands (100): | (24.42 - 30.38) | Sell |
Intellia Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 20.76 while NTLA 8-day simple moving average is 21.22, which is a Sell signal.
- The stock price of NTLA is 20.76 while Intellia Therapeutics 20-day SMA is 23.36, which makes it a Sell.
- Intellia Therapeutics 50-day simple moving average is 26.53 while NTLA share price is 20.76, making it a Sell technically.
- NTLA stock price is 20.76 and Intellia Therapeutics 200-day simple moving average is 30.62, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
26
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a Sell
The current Intellia Therapeutics [NTLA] share price is $20.76. The Score for NTLA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
2B
Price in USD:
20.76
Share Volume:
1.02M
Intellia Therapeutics 52-Week Range
52-Week High:
47.48
52-Week Low:
19.37
Sell
26
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?
The Intellia Therapeutics stock price is 20.76 USD today. -
Will NTLA stock go up or go down?
Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Intellia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 20.76 while NTLA 8-day exponential moving average is 21.41, which is a Sell signal.
- The stock price of NTLA is 20.76 while Intellia Therapeutics 20-day EMA is 23.08, which makes it a Sell.
- Intellia Therapeutics 50-day exponential moving average is 25.29 while NTLA share price is 20.76, making it a Sell technically.
- NTLA stock price is 20.76 and Intellia Therapeutics 200-day simple moving average is 30.63, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.02 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
- NTLA Moving Average Covergence Divergence (MACD) indicator is -1.71, suggesting Intellia Therapeutics is a Sell
- Intellia Therapeutics Relative Strength Index (RSI) is 31, which suggest Intellia Therapeutics is oversold
- The Bollinger Bands (25) for Intellia Therapeutics is (21.75 - 26.39), which suggest Intellia Therapeutics is a Sell
- The Bollinger Bands (100) for Intellia Therapeutics is (24.42 - 30.38), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.